Transamerica Financial Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Buy
4,673
+1,376
+42% +$67K 0.02% 387
2026
Q1
$141K Buy
3,297
+2,168
+192% +$93.2K 0.01% 451
2025
Q4
$49.5K Buy
1,129
+821
+267% +$34K ﹤0.01% 551
2025
Q3
$12.7K Buy
+308
New +$12.4K ﹤0.01% 685
2021
Q3
– Sell
-11
Closed -$1K – 144
2021
Q2
$1K Buy
+11
New +$257 0.02% 119

Other funds holding EXEL

Transamerica Financial Advisors's EXEL Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Exelixis (EXEL) stake by 42% in Q2 2026, buying an estimated $67K and bringing the position to 4,673 shares worth $254K. The position accounts for 0.02% of the portfolio, ranked #387.

Transamerica Financial Advisors first reported a position in EXEL in Q2 2021 and has held it in 5 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Transamerica Financial Advisors held 4,673 shares of Exelixis worth $254K as of Q2 2026.
  • Transamerica Financial Advisors bought 1,376 Exelixis shares in Q2 2026, an estimated $67K.
  • Exelixis made up 0.02% of Transamerica Financial Advisors's portfolio in Q2 2026, its #387 holding.
  • Transamerica Financial Advisors first reported a position in Exelixis in Q2 2021 and has held it in 5 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.